Advertisement
Home Tags Pneumonia

Tag: Pneumonia

El microbioma pulmonar podría tener un rol en el cáncer

Some Inflammatory Diseases Linked to Stroke-Associated Pneumonia

0

Risk for SAP reduced among patients with psoriasis, other chronic inflammatory diseases among acute ischemic stroke discharges

ACG: Resilience-Based Care Coordination Program Benefits IBD

Crohn Disease, Comorbidities Up Risk for Severe Pneumococcal Disease

0

Receipt of PCV13 alone or in combination with PPSV23 predicts fivefold reduced risk for SPD compared with no vaccination

Hospital Mortality Up for Critically Ill With COVID-19 Vs. Flu

Cadmium Burden Linked to Mortality From Flu, Pneumonia

0

Risk for related mortality increased with urinary cadmium in the 80th versus the 20th percentile in whole population, never smokers in NHANES-III

La vacuna de Pfizer contra la COVID parece promisoria

Tocilizumab Cuts Progression to Ventilation or Death in COVID-19

0

But death from any cause by day 28 in those hospitalized with COVID-19 pneumonia did not differ for tocilizumab versus placebo

Los pacientes con la peor COVID-19 quizá sean los mejores donantes de plasma

COVID-19 Outcomes Not Improved With Convalescent Plasma

0

Clinical status, mortality did not differ for convalescent plasma versus placebo in adults with severe COVID-19 pneumonia

High SARS-CoV-2 Genomic Load Tied to Worse Outcomes

0

Genomic load independent risk factor for composite outcome of death, intubation, ECMO

Current angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use is associated with a slightly lower mortality risk in patients hospitalized with influenza or pneumonia

Certain HTN Meds May Cut Deaths From Influenza, Pneumonia

0
Use of ACE-I/ARB versus nonuse linked to lower mortality for those hospitalized with flu, pneumonia
Children who have bronchitis at least once before the age of 7 years are more likely to develop lung problems in later life

Bronchitis in Early Childhood Linked to Later Lung Disease

0
Lung diseases occurring later in life more likely to be asthma, pneumonia rather than chronic bronchitis
Patients with moderate COVID-19 receiving a five-day course of remdesivir have a statistically significant difference in clinical status compared with usual care

Clinical Impact of Remdesivir in Moderate COVID-19 Unclear

0
Significant difference seen in clinical status versus usual care for five-day, but not 10-day, course
For patients with hip fracture

Pneumonia Risk Down With Nitrogen-Containing Bisphosphonates

0
Reductions in risk for pneumonia and pneumonia mortality seen among patients with hip fracture